Mon. 1 Apr 2024, 7:04am ET
Benzinga
Earnings, News
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the same period last year.